adagrasib
mirati
['lcsm,(-blcsm)', 'lung', 'krystal-1', 'sclc', 'nsclc', 'adagrasib']
#asco22 day 1: #lungcancer highlights 2/6 #krystal-1 #adagrasib in krasg12c nsclc
n=116 orr 42.9% , mdor 8.5mos, mos 12.6mos stable cns orr 33.3% drug discontinuation 7% just published: #lcsm #medtwitter 
Associate Director Community Outreach- Thoracic Oncology-University of Miami @SylvesterCancer , Boricua en la Luna, Tweets are my own. (she/her)